Immunisation Against Infectious Diseases

Understanding Immunisation

Immunisation, also known as vaccination, is one of the most effective public health interventions for preventing infectious diseases. By stimulating the body's immune system to recognize and fight specific disease-causing organisms, vaccines provide protection without causing the actual illness.

The principle behind immunisation is remarkably simple: expose the immune system to a weakened or inactivated form of a pathogen, allowing it to develop antibodies and immunological memory. When the body encounters the actual pathogen in the future, it can respond rapidly and effectively, often preventing infection entirely or reducing its severity.

According to the World Health Organization (WHO), immunisation currently prevents 2-3 million deaths every year from diseases like diphtheria, tetanus, pertussis, influenza, and measles. If global vaccination coverage were improved, an additional 1.5 million deaths could be prevented annually.

The Importance of Vaccination

Vaccines provide individual protection and contribute to community health through herd immunity. This concept occurs when a sufficient proportion of a population becomes immune to an infection, reducing the likelihood of infection for individuals who lack immunity. Herd immunity protects those who cannot receive vaccines due to medical conditions, age, or other factors.

Key Benefits of Immunisation:

• Prevention of potentially fatal diseases
• Reduced healthcare costs associated with treating preventable illnesses
• Protection of vulnerable populations who cannot be vaccinated
• Contribution to global health security and pandemic prevention
• Societal and economic benefits through reduced illness-related absenteeism

How Vaccines Work

Vaccines work by mimicking the infection of certain diseases, stimulating the immune system to produce a protective response. When a vaccine enters the body, the immune system identifies the antigens (foreign substances) as potential threats and mounts a defense.

The immune response involves:

• Recognition of the antigen by white blood cells
• Production of antibodies specific to the antigen
• Creation of memory B cells that "remember" how to produce these antibodies

If the body is later exposed to the actual disease-causing germ, the immune system can recognize it quickly and produce antibodies to fight it, often before symptoms develop.

Types of Vaccines

Scientists have developed various types of vaccines, each utilizing different approaches to stimulate the immune system:

Live-attenuated vaccines

These contain weakened forms of the virus or bacteria that cause the disease. They typically create strong and long-lasting immunity from one or two doses. Examples include vaccines for measles, mumps, rubella (MMR), chickenpox, and rotavirus.

Inactivated vaccines

These contain killed versions of the virus or bacteria. They may require multiple doses or booster shots to maintain immunity. Examples include polio, hepatitis A, and flu shots.

Subunit, recombinant, polysaccharide, and conjugate vaccines

These use specific pieces of the germlike its protein, sugar, or capsidto trigger an immune response. Examples include hepatitis B, HPV, whooping cough, pneumococcal, and meningococcal vaccines.

Toxoid vaccines

These contain a toxin (harmful product) made by the germ rather than the germ itself. Examples include diphtheria and tetanus vaccines.

mRNA vaccines

A newer technology that teaches our cells how to make a protein that triggers an immune response. COVID-19 vaccines have successfully used this technology.

Viral vector vaccines

These use a modified version of a different virus to deliver important instructions to our cells. Several COVID-19 vaccines employ this approach.

Recommended Vaccination Schedules

Health authorities worldwide recommend specific vaccination schedules to provide optimal protection throughout life. While schedules may vary between countries, most follow similar principles based on when individuals are most vulnerable to specific diseases.

Childhood Immunisations

Early childhood vaccination programs target diseases that can be particularly dangerous for young children. Many countries provide routine vaccines for:

• Hepatitis B
• Diphtheria, tetanus, and pertussis (DTaP)
• Haemophilus influenzae type b (Hib)
• Polio
• Pneumococcal disease
• Rotavirus
• Measles, mumps, and rubella (MMR)
• Chickenpox
• Seasonal influenza

Adolescent Vaccinations

Recommended vaccines for adolescents include:

• HPV (human papillomavirus) vaccine
• Meningococcal disease vaccines
• Tdap (tetanus, diphtheria, and pertussis) booster
• Annual influenza vaccine

Adult Vaccinations

Adults should maintain immunization to protect themselves and those around them. Recommendations include:

• Annual influenza vaccine
• Tetanus, diphtheria booster every 10 years
• Shingles vaccine (for older adults)
• Pneumococcal vaccines (for those with risk factors and older adults)
• Other vaccines based on health status, age, occupation, and travel

Vaccine Safety and Monitoring

Vaccines undergo rigorous testing before approval and continue to be monitored after deployment to ensure safety and effectiveness. The comprehensive vaccine development process includes:

• Preclinical testing in laboratories and animals
• Clinical trials involving human volunteers in multiple phases
• Licensing approval by regulatory agencies such as the FDA and EMA
• Post-marketing surveillance to monitor real-world vaccine performance

Vaccine safety monitoring systems include:

• Vaccine Adverse Event Reporting System (VAERS) - collects reports of possible adverse events
• Clinical Immunization Safety Assessment Project - investigates complex vaccine safety questions
• Vaccine Safety Datalink - evaluates vaccine safety in large populations
• The WHO Global Advisory Committee on Vaccine Safety, which provides independent scientific advice

Addressing Vaccine Misconceptions

Despite scientific evidence supporting vaccine safety and efficacy, misconceptions persist. Understanding and addressing these concerns is essential for maintaining vaccine confidence.

"Vaccines cause autism"

Extensive research has found no link between vaccines and autism. The original study proposing this connection was found to be seriously flawed and was eventually retracted. Numerous subsequent studies involving millions of children have confirmed no association.

"Natural immunity is better than vaccine-acquired immunity"

While natural infection sometimes provides stronger immunity, it comes with significant risks including serious complications and death. Vaccines provide immunity without these dangers.

"Vaccines contain harmful toxins"

Vaccine ingredients are present in amounts that are safe and serve important functions. For example, aluminum salts help boost immune response and have been used safely in vaccines for decades.

"Too many vaccines overwhelm the immune system"

Infants encounter countless antigens daily. Vaccines contain only a tiny fraction of the antigens they experience naturally. The human immune system is capable of responding to millions of antigens simultaneously.

Global Immunisation Efforts

Immunisation is a global health priority, with organizations like the WHO, UNICEF, Gavi, the Vaccine Alliance, and national governments working to improve vaccine equity and access.

The Expanded Programme on Immunization (EPI)

Established by WHO in 1974, the EPI originally targeted six childhood diseases and has since expanded to include additional vaccines, significantly increasing global immunization coverage and reducing childhood mortality.

Gavi, the Vaccine Alliance

Founded in 2000, Gavi is a public-private partnership that aims to increase access to immunization in poor countries. It has contributed to the immunization of more than 760 million children, preventing more than 13 million future deaths.

Cold Chain Management

Maintaining proper temperatures during vaccine storage and distribution is crucial for vaccine efficacy. Global efforts continue to improve cold chain infrastructure, particularly in low-resource settings.

The Future of Immunisation

Ongoing research and innovation continue to expand the possibilities of immunisation. Exciting developments include:

• mRNA technology beyond COVID-19, being explored for influenza, HIV, and malaria
• Universal influenza vaccines that wouldn't need annual updating
• HIV vaccine development, with several candidates now in clinical trials
• Malaria vaccines, with the RTS,S/AS01 vaccine implementation program beginning in several African countries
• Personalized cancer vaccines that train the immune system to recognize tumor-specific antigens
• Needle-free delivery systems like microneedle patches and nasal sprays

Conclusion

Immunisation represents one of humanity's greatest public health achievements. Through scientific advancement, we've developed tools to prevent diseases that once caused widespread suffering. Maintaining high vaccination rates is essential to preserve these gains and protect future generations.

As the field continues to evolve with new technologies, the potential to prevent even more diseases grows. Continued investment in immunisation infrastructure, education, and research will ensure that all people can benefit from these life-saving interventions.